|
1
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Gilabert M, Bruix J and Raoul
JL: Treatment of intermediate-stage hepatocellular carcinoma. Nat
Rev Clin Oncol. 11:525–535. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Plaks V, Kong N and Werb Z: The cancer
stem cell niche: How essential is the niche in regulating stemness
of tumor cells? Cell Stem Cell. 16:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao W, Wang L, Han H, Jin K, Lin N, Guo
T, Chen Y, Cheng H, Lu F, Fang W, et al: 1B50-1, a mAb raised
against recurrent tumor cells, targets liver tumor-initiating cells
by binding to the calcium channel α2δ1 subunit. Cancer Cell.
23:541–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Markowska A, Sajdak S, Markowska J and
Huczynski A: Angiogenesis and cancer stem cells: New perspectives
on therapy of ovarian cancer. Eur J Med Chem. 142:87–94. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zimmerer RM, Ludwig N, Kampmann A,
Bittermann G, Spalthoff S, Jungheim M, Gellrich NC and Tavassol F:
CD24+ tumor-initiating cells from oral squamous cell carcinoma
induce initial angiogenesis in vivo. Microvasc Res. 112:101–108.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng YB, Gong JH, Liu XJ, Li Y and Zhen
YS: A CD13-targeting peptide integrated protein inhibits human
liver cancer growth by killing cancer stem cells and suppressing
angiogenesis. Mol Carcinog. 56:1395–1404. 2017. View Article : Google Scholar
|
|
8
|
Kumar D, Kumar S, Gorain M, Tomar D, Patil
HS, Radharani NNV, Kumar TVS, Patil TV, Thulasiram HV and Kundu GC:
Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem
Cell-Mediated Melanoma Growth and Angiogenesis. J Invest Dermatol.
136:2462–2474. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yi SY, Ruan J, Zhao L, Ke Y and Li XN:
Metronomic gemcitabine targeted tumor vascular microenvironment
decreases the population of CD133(+) cells in hepatocarcinoma
xenografts. Cancer Biomark. 14:427–433. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maehara O, Sato F, Natsuizaka M, Asano A,
Kubota Y, Itoh J, Tsunematsu S, Terashita K, Tsukuda Y, Nakai M, et
al: A pivotal role of Krüppel-like factor 5 in regulation of cancer
stem-like cells in hepatocellular carcinoma. Cancer Biol Ther.
16:1453–1461. 2015. View Article : Google Scholar
|
|
11
|
Richtig G, Aigelsreiter A, Schwarzenbacher
D, Ress AL, Adiprasito JB, Stiegelbauer V, Hoefler G, Schauer S,
Kiesslich T, Kornprat P, et al: SOX9 is a proliferation and stem
cell factor in hepatocellular carcinoma and possess widespread
prognostic significance in different cancer types. PLoS One.
12:e01878142017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou S, Wang C, Liu J, Wang Q, Zhang D, Zhu
S, Xu S, Kang M and He S: Sox12 Is a Cancer Stem-Like Cell Marker
in Hepatocellular Carcinoma. Mol Cells. 40:847–854. 2017.PubMed/NCBI
|
|
13
|
Mirshahidi S, Simental A, Lee SC, De
Andrade Filho PA, Peterson NR, Cao W, Necochea-Campion R, Yang H,
Duerksen-Hughes P and Yuan X: Subpopulations of cancer stem cells
found in papillary thyroid carcinoma. Exp Cell Res. 362:515–524.
2018. View Article : Google Scholar
|
|
14
|
Jin B, Wang W, Meng XX, Du G, Li J, Zhang
SZ, Zhou BH and Fu ZH: Let-7 inhibits self-renewal of
hepatocellular cancer stem-like cells through regulating the
epithelial-mesenchymal transition and the Wnt signaling pathway.
BMC Cancer. 16:8632016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park IS, Chung PS and Ahn JC:
Adipose-derived stem cell spheroid treated with low-level light
irradiation accelerates spontaneous angiogenesis in mouse model of
hindlimb ischemia. Cytotherapy. 19:1070–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ribeiro AL, Kaid C, Silva PBG, Cortez BA
and Okamoto OK: Inhibition of Lysyl Oxidases Impairs Migration and
Angiogenic Properties of Tumor-Associated Pericytes. Stem Cells
Int. 2017:49720782017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie Q, Xie J, Tian T, Ma Q, Zhang Q, Zhu B
and Cai X: Hypoxia triggers angiogenesis by increasing expression
of LOX genes in 3-D culture of ASCs and ECs. Exp Cell Res.
352:157–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bae WJ, Yi JK, Park J, Kang SK, Jang JH
and Kim EC: Lysyl oxidase-mediated VEGF-induced differentiation and
angio-genesis in human dental pulp cells. Int Endod J. 51:335–346.
2018. View Article : Google Scholar
|
|
19
|
Zhu J, Huang S, Wu G, Huang C, Li X, Chen
Z, Zhao L and Zhao Y: Lysyl Oxidase Is Predictive of Unfavorable
Outcomes and Essential for Regulation of Vascular Endothelial
Growth Factor in Hepatocellular Carcinoma. Dig Dis Sci.
60:3019–3031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tse AP, Sze KM, Shea QT, Chiu EY, Tsang
FH, Chiu DK, Zhang MS, Lee D, Xu IM, Chan CY, et al: Hepatitis
transactivator protein X promotes extracellular matrix modification
through HIF/LOX pathway in liver cancer. Oncogenesis. 7:442018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Y, Xiao Q, Ma H, Li L, Liu J, Feng Y,
Fang Z, Wu J, Han X, Zhang J, et al: LKB1 inhibits lung cancer
progression through lysyl oxidase and extracellular matrix
remodeling. Proc Natl Acad Sci USA. 107:18892–18897. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pickup MW, Laklai H, Acerbi I, Owens P,
Gorska AE, Chytil A, Aakre M, Weaver VM and Moses HL: Stromally
derived lysyl oxidase promotes metastasis of transforming growth
factor-β-deficient mouse mammary carcinomas. Cancer Res.
73:5336–5346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kucharzewska P, Christianson HC, Welch JE,
Svensson KJ, Fredlund E, Ringnér M, Mörgelin M, Bourseau-Guilmain
E, Bengzon J and Belting M: Exosomes reflect the hypoxic status of
glioma cells and mediate hypoxia-dependent activation of vascular
cells during tumor development. Proc Natl Acad Sci USA.
110:7312–7317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsuura S, Mi R, Koupenova M, Eliades A,
Patterson S, Toselli P, Thon J, Italiano JE Jr, Trackman PC,
Papadantonakis N, et al: Lysyl oxidase is associated with increased
thrombosis and platelet reactivity. Blood. 127:1493–1501. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pietras A, Katz AM, Ekström EJ, Wee B,
Halliday JJ, Pitter KL, Werbeck JL, Amankulor NM, Huse JT and
Holland EC: Osteopontin-CD44 signaling in the glioma perivascular
niche enhances cancer stem cell phenotypes and promotes aggressive
tumor growth. Cell Stem Cell. 14:357–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berretta M, Rinaldi L, Di Benedetto F,
Lleshi A, De Re V, Facchini G, De Paoli P and Di Francia R:
Angiogenesis Inhibitors for the Treatment of Hepatocellular
Carcinoma. Front Pharmacol. 7:4282016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Montella L, Addeo R, Caraglia M and Del
Prete S: Latest developments in targeted therapy for hepatocellular
carcinoma. Expert Rev Anticancer Ther. 10:1635–1646. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Y, Liu YC, Sung YC, Ramjiawan RR, Lin
TT, Chang CC, Jeng KS, Chang CF, Liu CH, Gao DY, et al: Overcoming
sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted
nanoparticles to co-deliver MEK-inhibitors. Sci Rep. 7:441232017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao JJ, Shi ZY, Xia JF, Inagaki Y and Tang
W: Sorafenib-based combined molecule targeting in treatment of
hepatocellular carcinoma. World J Gastroenterol. 21:12059–12070.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Trojan J and Waidmann O: Role of
regorafenib as second-line therapy and landscape of investigational
treatment options in advanced hepatocellular carcinoma. J
Hepatocell Carcinoma. 3:31–36. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu XL, Xing BC, Han HB, Zhao W, Hu MH, Xu
ZL, Li JY, Xie Y, Gu J, Wang Y, et al: The properties of
tumor-initiating cells from a hepatocellular carcinoma patient’s
primary and recurrent tumor. Carcinogenesis. 31:167–174. 2010.
View Article : Google Scholar
|
|
32
|
Su B, Zhao W, Shi B, Zhang Z, Yu X, Xie F,
Guo Z, Zhang X, Liu J, Shen Q, et al: Let-7d suppresses growth,
metastasis, and tumor macrophage infiltration in renal cell
carcinoma by targeting COL3A1 and CCL7. Mol Cancer. 13:2062014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
34
|
Liu C, Guo C, Wang W, Zhu P, Li W, Mi Y,
Myatt L and Sun K: Inhibition of Lysyl Oxidase by Cortisol
Regeneration in Human Amnion: Implications for Rupture of Fetal
Membranes. Endocrinology. 157:4055–4065. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng T, Sun X, Wu J, Wang M, Eisenberg RA
and Chen Z: Increased serum levels of tumor necrosis factor
receptor-associated factor 1 (TRAF1) correlate with disease
activity and autoantibodies in rheumatoid arthritis. Clin Chim
Acta. 462:103–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shu Q, Li W, Li H and Sun G: Vasostatin
inhibits VEGF-induced endothelial cell proliferation, tube
formation and induces cell apoptosis under oxygen deprivation. Int
J Mol Sci. 15:6019–6030. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Giacomini A, Ackermann M, Belleri M,
Coltrini D, Nico B, Ribatti D, Konerding MA, Presta M and Righi M:
Brain angioar-chitecture and intussusceptive microvascular growth
in a murine model of Krabbe disease. Angiogenesis. 18:499–510.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press (US); Washington, DC: 2011
|
|
39
|
Pathan M, Keerthikumar S, Chisanga D,
Alessandro R, Ang CS, Askenase P, Batagov AO, Benito-Martin A,
Camussi G, Clayton A, et al: A novel community driven software for
functional enrichment analysis of extracellular vesicles data. J
Extracell Vesicles. 6:13214552017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A Portal for Facilitating Tumor Subgroup Gene
Expression and Survival Analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hodo Y, Honda M, Tanaka A, Nomura Y, Arai
K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Sakai A, et al:
Association of interleukin-28B genotype and hepatocellular
carcinoma recurrence in patients with chronic hepatitis C. Clin
Cancer Res. 19:1827–1837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Osawa T, Ohga N, Akiyama K, Hida Y,
Kitayama K, Kawamoto T, Yamamoto K, Maishi N, Kondoh M, Onodera Y,
et al: Lysyl oxidase secreted by tumour endothelial cells promotes
angiogenesis and metastasis. Br J Cancer. 109:2237–2247. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu J, Guo W, Xu B, Ran F, Chu M, Fu H and
Cui J: Angiogenesis inhibition and cell cycle arrest induced by
treatment with Pseudolarix acid B alone or combined with
5-fluorouracil. Acta Biochim Biophys Sin (Shanghai). 44:490–502.
2012. View Article : Google Scholar
|
|
44
|
Bisacchi D, Benelli R, Vanzetto C, Ferrari
N, Tosetti F and Albini A: Anti-angiogenesis and angioprevention:
Mechanisms, problems and perspectives. Cancer Detect Prev.
27:229–238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li M, Li M, Yin T, Shi H, Wen Y, Zhang B,
Chen M, Xu G, Ren K and Wei Y: Targeting of cancer associated
fibroblasts enhances the efficacy of cancer chemotherapy by
regulating the tumor microenvironment. Mol Med Rep. 13:2476–2484.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Semenza GL: Cancer-stromal cell
interactions mediated by hypoxia-inducible factors promote
angiogenesis, lymphangio-genesis, and metastasis. Oncogene.
32:4057–4063. 2013. View Article : Google Scholar
|
|
47
|
Nareshkumar RN, Sulochana KN and Coral K:
Inhibition of angiogenesis in endothelial cells by Human Lysyl
oxidase propeptide. Sci Rep. 8:104262018. View Article : Google Scholar : PubMed/NCBI
|
